Detecting Individual Differences in Changes in Memory Functioning Dr. Len Lecci Professor of Psychology University of North Carolina Wilmington Director.

Slides:



Advertisements
Similar presentations
Indianapolis Discovery Network for Dementia Comparative Effectiveness Research Trial of Alzheimers Disease Drug: COMET-AD.
Advertisements

APOE Genotype Effects on Alzheimer’s Disease Clinical Onset, Epidemiology, and Gompertzian Aging Functions J.Wesson Ashford, M.D., Ph.D. Stanford / VA.
Living well with dementia: more timely diagnosis and early intervention Louise Robinson Professor of Primary Care and Ageing RCGP National Clinical Champion.
Management of Early Dementia Dr Eleanor Mullan Consultant Psychiatrist Mental Health Services for Older People South Lee, Cork Feb 2011.
New England Journal of Medicine October 18;367: Relapse Risk after Discontinuation of Risperidone in Alzheimer’s disease Molly Moncrieff.
Public Health Impact of Dementia Terrie Fox Wetle, MS, Ph.D. Associate Dean of Medicine for Public Health Professor, Health Services, Policy & Practice.
DRAFT Promotional Copy for NNSDO 1 Cognitive / Mental Status Assessment of Older Adults.
1 Alzheimer’s Disease Who is Affected? Presented by Maria C. Carrillo, Ph.D. Alzheimer’s Association December 2010.
Dementia & Delirium in Surgical Patients Damian Harding Department of Geriatric Medicine February 2008.
Screening By building screening for symptoms of VCI into regular workflows or practice, health care providers are participating in Taking Action to address.
The New Brief Cognitive Assessment Tool (BCAT): The Role of Cognitive Assessment in Improving Health Outcomes Dr. William Mansbach October 25, 2011.
Mild Cognitive Impairment as a Target for Drug Development Steven H. Ferris, Ph.D. Silberstein Aging and Dementia Research Center New York University School.
ACT on Alzheimer’s Disease Curriculum Module VII: Disease Diagnosis.
Prescreening ä To optimize safety ä To permit the development of a sound and effective exercise prescription.
Multiple Sclerosis: A Neuropsychological Perspective National Multiple Sclerosis Society: Eastern North Carolina Chapter Antonio E. Puente, Ph.D. University.
Alzheimer's Disease Guadalupe Lupian Mrs. Marsh 1 st period.
Introduction Over the years a variety of different tools have been developed to test cognition and screen for cognitive impairment. The NICE guideline.
Alzheimer’s Assessment Assessing the Cognitive-Linguistic effects of Alzheimer’s.
Indianapolis Discovery Network for Dementia Forecasting the Future Impact of Early Detection and Management Program for Alzheimer.
Indianapolis Discovery Network for Dementia Comparative Effectiveness Research Trial of Alzheimer’s Disease Drugs: COMET-AD.
Training the trainer Training of clinical psychologists for pedagogic activity Dr. Gilles Michaux Training of clinical psychologists for pedagogic activity.
Risk of Developing Alzheimer’s Disease in Persons with MCI
Changing Practice in Nursing and Care Homes National Dementia Learning Event 29 th September 2011 Jillian Torrens, Adult Services Manager, Glasgow CHP.
Decision presented by the committee board members: Nicholas Mann & Katelyn Strasser FUTURE FUNDING FOR ALZHEIMER’S DISEASE October 14, 2014 MPH 543 Leadership.
ALZHEIMER’S DISEASE BY OLUFOLAKUNMI KEHINDE PRE-MD 1.
Clear organic causes, where primary symptom is a significant deficit in cognitive ability changes in the person’s personality and behavior (due to the.
Delirium in the acute hospital
Working with Memory Problems Presented by Dr Nigel George Clinical Psychologist.
Copyright © 2007, 2003 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 37 Confusion and Dementia.
Progress Report on Alzheimer’s Disease Taking the Next Steps NIA NIH.
LISA JOHNSON & SUZANNE GRIESEL MPH 543 LEADERSHIP AND ORGANIZATIONAL BEHAVIOR FEBRUARY 16, 2014 Funding Analysis of Alzheimer’s Treatment Options: Three.
Geriatric Psychiatry Services JoAnn Pelletier-Bressette, RN, Nurse Manager Nancy Hooper, BScN, RN, CPMHN (C) 1.
How To Improve Memory Performance and Keep Your Brain Young Gary W. Small, MD Parlow-Solomon Professor on Aging Professor of Psychiatry & Biobehavioral.
Alzheimer’s Disease Tessa Dillon Nova Southeastern University Clinical Genetics Teri Doolittle, PA-C, MHP, DHSc August 3, 2008.
Defining Mild Cognitive Impairment Steven T.DeKosky, M.D. Director, Alzheimer’s Disease Research Center University of Pittsburgh Pittsburgh, PA.
Introduction Anticipatory care plans were introduced in October 2011 as part of the enhanced service contract for general practice, with the aim of reducing.
Introduction: Medical Psychology and Border Areas
Dr K N Prasad Community Medicine
NOW WHERE HAVE I PUT MY GLASSES? A DISCUSSION AROUND DEMENTIA Dr Marion Overton U3A SCIENCE 19TH JUNE 2015.
Why Physicians Do Not Diagnose Alzheimer’s Disease Mark A. Sager, MD Professor of Medicine and Population Health Sciences Director, Wisconsin Alzheimer’s.
1 From Cause to Movement Shaping a World Without Alzheimer’s Through Advocacy, Volunteerism, Referral and Science Ian Kremer, Esq. Advocacy & Outreach.
COLUMBIA PRESBYTARIAN HOSPITAL CENTER
Dementia. What is Dementia? Dementia is a gradual decline of mental ability that affects your intellectual and social skills to the point where daily.
Cognitive Disorders Chapter 15. Defined as when a human being can no longer understand facts or connect the appropriate feelings to events, they have.
“3 D’s” of Geriatrics Dementia, Delirium, and Depression These common disorders can look alike. GAI often helps uncover or differentiate them. All are.
PRE-DOCTORAL INTERNSHIPS IN PSYCHOLOGY Brown Bag 11/14/11.
RNSG 1163 Summer Qe8cR4Jl10.
Is It Alzheimer’s? The Latest Update on Optimal Evaluation and Treatment of Patients with Memory Loss Majid Fotuhi, MD PhD March 5, 2014.
GERIATRIC EDUCATION SERIES Presented in partnership by Funded in part by a grant from the EJC Foundation.
Break In To Groups (15 Minutes) You will work in discussion groups that were assigned yesterday at the end of class You will work in discussion groups.
Mosby items and derived items © 2008 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 44 Confusion and Dementia.
Module 3: Alzheimer’s Disease – What is the Role of Public Health? A Public Health Approach to Alzheimer’s and Other Dementias.
Dementia: Alzheimer’s Disease Cyril Evbuomwan Patient Group Meeting 1 st December 2015.
Cognitive Disorders Chapter 13 Nature of Cognitive Disorders: An Overview Perspectives on Cognitive Disorders Cognitive processes such as learning, memory,
The Alzheimer’s Disease Challenge: Take Your Knowledge Further ALZHEIMER’S DISEASE AND ITS MANAGEMENT: AN OVERVIEW.
Additional Assessments. Clinicians are encouraged to communicate with the interprofessional team about other resources and next steps in terms of additional.
Dementia Diagnosis: Why should we bother? Dr. Sridhar Vaitheswaran 30 th October 2013.
Alzheimer’s disease.
Can we treat Alzheimers 20 years early? 郭丕鈺 王家豪 張琮貿.
By: Azadeh Myers Period 2. Definition A common form of dementia of unknown cause usually beginning in the late middle age, characterize by progressive.
1 Cognitive Impairment and Dementia: What You Need to Know about Alzheimer's Disease and Related Disorders Part 2 – Clinical focus Susan Rowlett, LICSW.
Orientation to Early Memory Loss. Let’s look for some answers… What is happening? What should I do? Where should I go?
Types of Dementia Dr Bernie Coope Associate Medical Director/Honorary Senior Lecturer, Worcester University Association for Dementia Studies.
Copyright © 2008 Delmar. All rights reserved. Chapter 4 Epidemiology and Public Health Nursing.
Memory and Aging Educational Presentation Presented by Tessa Lundquist, M.S. University of Massachusetts Amherst.
Chapter 10: Nursing Management of Dementia
Cognitive Changes in Myotonic Dystrophy
Dementia Jaqueline Raetz, M.D..
Best Practices to Simplify and Optimize
Progress Report on Alzheimer’s Disease
Presentation transcript:

Detecting Individual Differences in Changes in Memory Functioning Dr. Len Lecci Professor of Psychology University of North Carolina Wilmington Director of Clinical Services Memory Assessment & Research Services

Trends in MCI and Alzheimer’s Unvergatz et al, 2001

The incidence of dementia Less than half of the population (45%) aged 84 and older is cognitively normal - NIH, 2001 Prevalence Rates Age Alzheimer’s Disease All Dementias % 1% % 2% % 4% % 8% % 16% 85 & older22.8% 30-45% Rates for each person would also vary depending upon your risk factors, genetic predisposition, etc, all of which can double, triple, or quadruple your risk. –Prevalence Rates based on the most recent Report to the Surgeon General, 1999

Degenerative Pattern of Neurons

Rate of memory decline increases 5.1 years before dementia diagnosis (Hall et al, 2000) The Course of Dementia

New and Emerging Treatments New Medications –Cholinergic Enhancers (e.g., Aricept, Reminyl/Razadyne, Exelon, Cognex) –Neuroprotectors/cell death blocker (Namenda) –Anti-beta amyloid drugs (Phase III trials)

Early Detection and Treatment of Memory Loss Greatly Improves Quality of Life

Benefits of early detection/intervention At current rates of nursing home admissions, a one-month delay would save more than $1 billion annually in Alzheimer care costs alone in the U.S. Treatments that delay onset by five years would reduce the number of individuals with Alzheimer’s disease by nearly 50% after 50 years. Alzheimer’s Association and the National Institute on Aging

Profound Impairment Induction Latency MCI Years Prior to Diagnosis Cognitive Performance Diagnosis Subtle Signs Normal Aging

Do I have a memory problem? Normal forgetting or early signs of a serious problem? Subjective self-assessment of memory functioning based on anecdotal experiences (long vs. short term memory) Research: Individuals with cognitive impairments (memory deficits) do not typically realize that they have these problems –self-reported assessments are ineffective

Detecting dementia during routine physical exams < 3% of those evidencing the early stages of dementia are detected during routine physical exams < 25% of those evidencing moderate to severe dementia are detected during routine physical exams –Report to the Surgeon General, 1999 –Time constraints –Limited specialized training in memory evaluations –Inaccurate self–report of patients –Limited use of standardized measures –Influenced by verbal skills of the patient –One dimensional view of memory

Multi-Factorial View of Memory Cognitive Research Episodic Memory Temporal Memory Memory Search Sensory Memory Memory Size Memory Under Stress Working Memory Numerical Memory Autobiographical Memory Memory Framing Encoding Visual Memory

Most effective method for memory screening Using comprehensive, standardized, and validated tests to screen for memory impairment Thorough assessment of memory: Assessing visual and auditory memory, immediate and delayed memory, memory capacity, memory learning curves, etc. –Approximately minutes to administer (+ scoring) –Administered by a trained psychologist –Allows for comparisons with people of the same age Assess other cognitive areas as well *Assess more than once

Case Study 1: Mrs. H Time 2 assessment Time 1 assessment Normal course Performance Time 3 assessment Denotes time of first diagnosis Problematic course Treated

Who should be evaluated for memory problems? Anyone 55 or older: To establish a record of functioning. Risk Factors include: 1) Family history of dementia (48% if parent with early onset) 2) Type II diabetes, high BP, high cholesterol 3) Known or suspected CNS dysfunction (stroke, tumor, etc.) 4) If undergoing treatment (medication, surgery) that may effect a cognitive or behavioral change 5) Those already diagnosed with dementia to optimize treatment outcomes (i.e., more aggressive treatment).

MARS is located in the UNCW Executive Development Center in the Northeast Regional Library building at Landfall Center

Educational opportunities Undergraduate students completing advanced practicum placements –PSY 451 (3 credits per semester) Graduate students in psychology completing practicum and internship (hours towards licensure as LPAs) –Opportunities for extensive testing experience and weekly grand round reviews –Exposure to repeat testing with a sample of normal aging and progressive dementia cases Graduate students from the school of business –Interns and class projects Post doctoral training Job opportunities for UNCW graduates

Knowledge Transfer Memory Assessment and Research Services is part of the UNCW Knowledge Transfer Initiative. This initiative, as part of Technology Transfer, is intended to facilitate the transfer of knowledge from the academic setting to the community